hepatitis C vaccine
- Generic Name
- hepatitis C vaccine
Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus
- First Posted Date
- 2008-12-01
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Anza Therapeutics, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT00800007
- Locations
- 🇺🇸
Advanced Clinical Research Institute, Anaheim, California, United States
🇺🇸Alamo Medical Research, San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath